Auritec Pharmaceuticals
Pharmaceuticals, Santa Monica, California, 90401, United States, 1-10 Employees
Who is AURITEC PHARMACEUTICALS
Auritec Pharmaceuticals is an R&D company that specializes in innovative, sustained-release drug delivery systems. At Auritec, our focus is to leverage 20 years of experience from our sci...
Read More
- Headquarters: Santa Monica, California, 90401, United States
- Date Founded: 2002
- Employees: 1-10
- Revenue: Under $1 Million
- Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 4731
Does something look wrong? Fix it. | View contact records from AURITEC PHARMACEUTICALS
Auritec Pharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Auritec Pharmaceuticals
Answer: Auritec Pharmaceuticals's headquarters are located at Santa Monica, California, 90401, United States
Answer: Auritec Pharmaceuticals's official website is https://auritecpharma.com
Answer: Auritec Pharmaceuticals's revenue is Under $1 Million
Answer: Auritec Pharmaceuticals's SIC: 4731
Answer: Auritec Pharmaceuticals has 1-10 employees
Answer: Auritec Pharmaceuticals is in Pharmaceuticals
Answer: Auritec Pharmaceuticals contact info: Phone number: Website: https://auritecpharma.com
Answer: Auritec Pharmaceuticals is an R&D company that specializes in innovative, sustained-release drug delivery systems. At Auritec, our focus is to leverage 20 years of experience from our scientific team in extended release delivery systems in a basic and applied research environment. Our early success in securing National Institute of Health (NIH) funding for much of this work is indicative of the level of expertise and the advanced state of Auritec's technology. In no other time in the history of pharmaceutical sciences has drug delivery played as many roles in bringing new therapies to patients as it is doing now. With the advent of combinatorial chemistry and high-throughput screening in drug discovery, the physicochemical properties of new drug candidates are such that the development of bioavailable dosage forms is becoming extremely difficult. There are also major cellular barriers to overcome in targeting drugs to their sites of action. Additionally, drugs discovered based on genomic and other biotechnological research are difficult to deliver to their sites of action in therapeutically beneficial and commercially viable forms. Drug delivery is also playing major roles in the life-cycle management of older products.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month